X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Hemoglobinopathies Treatment Companies

This report lists the top Hemoglobinopathies Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Hemoglobinopathies Treatment industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Genetic Disorder Drugs Research Hemoglobinopathies Treatment Market Companies

Hemoglobinopathies Treatment Top Companies

  1. Sanofi S.A.

  2. Global Blood Therapeutics, Inc.

  3. bluebird bio, Inc.

  4. EMI Holding, Inc.

  5. Celgene Corporation

*Disclaimer: Top companies sorted in no particular order

Hemoglobinopathies Treatment Market Major Players

Hemoglobinopathies Treatment Market Concentration

Hemoglobinopathies Treatment Market Concentration

Hemoglobinopathies Treatment Company List

                            • Sanofi S.A.

                            • Global Blood Therapeutics, Inc.

                            • bluebird bio, Inc.

                            • EMI Holding, Inc.

                            • Celgene Corporation

                            • Gamida Cell

                            • Prolong Pharmaceuticals, LLC.

                            • Sangamo Therapeutics Inc.

                            • Silence Therapeutics


                        Specific to Hemoglobinopathies Treatment Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Hemoglobinopathies Treatment Report Snapshots

                        Hemoglobinopathies Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)